Near-infrared chemical imaging (NIR-CI) for counterfeit drug identification-A four-stage concept with a novel approach of data processing (Linear Image Signature)

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 1, 2010, Pages 138-145

  Puchert, T ^a   Lochmann, D ^b   Menezes, J C ^c   Reich, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Merck Serono GmbH   (Germany)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Counterfeits; Homogeneity; MVA; NIR CI; NIRS; QbD

Indexed keywords

BISOPROLOL FUMARATE;

ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; INFORMATION PROCESSING; NEAR INFRARED SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RELIABILITY; TABLET;

ANALYSIS OF VARIANCE; CHEMISTRY, PHARMACEUTICAL; MULTIVARIATE ANALYSIS; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; SPECTROSCOPY, NEAR-INFRARED; TABLETS;

EID: 70349428292     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.08.022     Document Type: Article

References (43)

1. Vredenbregt M.J., Mooiroek D., and Hoogerbrugge R. Your viagras-genuine, imitation, or counterfeit?. In: Burns D.A., and Ciurczak E.W. (Eds). Handbook of Near-Infrared Analysis (2007), CRC Press, Boca Raton 631-646
2. Vredenbregt M.J., Blok-Tip L., Hoogerbrugge R., Barends D.M., and Kaste D.D. Screening suspected counterfeit viagra(R) and imitations of viagra(R) with near-infrared spectroscopy. J. Pharm. Biomed. Anal. 40 (2006) 840-849
3. Singh S., Prasad B., Savaliya A.A., Shah R.P., Gohil V.M., and Kaur A. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. Trends Anal. Chem. 28 (2009) 13-28
4. Deisingh A.K. Pharmaceutical counterfeiting. Analyst 130 (2005) 271-279
5. World Health Organization. Counterfeit Drugs-Guidelines for the Development of Measures to Combat Counterfeit Drugs (1999), WHO, Geneva pp. 1-62
6. International Medical Products Anti-Counterfeiting Taskforce. Principles and Elements for National Legislation against Counterfeit Medical Products. IMPACT General Meeting Lisbon (2007) 1-13
7. http://ec.europa.eu/enterprise/pharmaceuticals/counterf_par_trade/counte rfeit_en.htm (2009) 1-1
8. U.S. Department of Health and Human Services: Food and Drug Administration. Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations (2006) pp. 1-32
9. World Health Organization, Forty-second Report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations, WHO Technical Report Series, No. 948 (2008) 1-150.
10. European Commission. Preparation of a Legislative Proposal to Combat Counterfeit Medicines for Human Use, Summary of Responses to the Public Consultation Document. Brüssel (2008) 1-11
11. Olsen B.A., Borer M.W., Perry F.M., and Forbes R.A. Screening for counterfeit drugs using near-infrared spectroscopy. Pharm. Technol. 26 (2002) 62-71
12. Dubois J., Wolff J.-C., Warrack J.K., Schoppelrei J., and Lewis E.N. NIR chemical imaging for counterfeit pharmaceutical products analysis. Spectroscopy (2007) 40-46
13. Rodionova O.Y., Houmøller L.P., Pomerantsev A.L., Geladi P., Burger J., Dorofeyev V.L., and Arzamastsev A.P. NIR spectrometry for counterfeit drug detection: a feasibility study. Anal. Chim. Acta 549 (2005) 151-158
14. World Health Organization. Basic Tests for Drugs: Pharmaceutical Substances, Medicinal Plant Materials and Dosage Forms (1998), WHO, Geneva pp. 1-94
15. Anderson C.A., Drennen J.K., and Ciurczak E.W. Pharmaceutical applications of near-infrared spectroscopy. In: Burns D.A., and Ciurczak E.W. (Eds). Handbook of Near-Infrared Analysis (2007), CRC Press, Boca Raton 585-612
16. Blanco M., Alcalá M., González J.M., and Torras E. A process analytical technology approach based on near infrared spectroscopy: Tablet hardness, content uniformity, and dissolution test measurements of intact tablets. Wiley InterScience 95 (2006) 2137-2144
17. Filmore D. Keeping an (infrared) eye out. Modern Drug Discovery September (2003) 35-40
18. ® counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometrics. J. Pharm. Biomed. Anal. 47 (2008) 688-694
19. Scafi S.H.F., and Pasquini C. Identification of counterfeit drugs using near-infrared spectroscopy. Analyst 126 (2001) 2218-2224
20. Yoon W.L. Near-infrared spectroscopy: a novel tool to detect pharmaceutical counterfeits. Am. Pharm. Rev. (2008) 115-118
21. Reich G. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv. Drug Deliv. Rev. 57 (2005) 1109-1143
22. Burger J., and Geladi P. Hyperspectral NIR imaging for calibration and prediction: a comparison between image and spectrometer data for studying organic and biological samples. Analyst 131 (2006) 1152-1160
23. Clarke F. Extracting process-related information from pharmaceutical dosage forms using near infrared microscopy. Vib. Spectrosc. 34 (2004) 25-35
24. Lewis E.N., Schoppelrei J., and Lee E. Near-infrared chemical imaging and the PAT initiative. Spectroscopy (2004) 26-34
25. Gendrin C., Roggo Y., and Collet C. Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review. J. Pharm. Biomed. Anal. 48 (2008) 533-553
26. Lee E., Huang W.X., Chen P., Lewis E.N., and Vivilecchia R.V. High-throughput analysis of pharmaceutical tablet content uniformity by near-infrared chemical imaging. Spectroscopy 21 (2006) 24-31
27. Roggo Y., Edmond A., Chalus P., and Ulmschneider M. Infrared hyperspectral imaging for qualitative analysis of pharmaceutical solid forms. Anal. Chim. Acta 535 (2005) 79-87
28. Dubois J., and Lewis E.N. Advanced Troubleshooting of Dissolution Failure (2009). http://www.pharmaceuticalonline.com/ pp. 38-45, Available from: www.pharmaceuticalonline.com
29. Makein L., Kidder L.H., Lewis E.N., and Valleri M. Non-destructive evaluation of manufacturing process changes using near infrared chemical imaging. NIR news 19 (2008) 11-15
30. Roggo Y., Jent N., Edmond A., Chalus P., and Ulmschneider M. Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imaging. Eur. J. Pharm. Biopharm. 61 (2005) 100-110
31. Westenberger B.J., Ellison C.D., Fussner A.S., Jenney S., Kolinski R.E., Lipe T.G., Lyon R.C., Moore T.W., Revelle L.K., Smith A.P., Spencer J.A., Story K.D., Toler D.Y., Wokovich A.M., and Buhse L.F. Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. Int. J. Pharm. 306 (2005) 56-70
32. Lyon R.C., Lester D.S., Lewis E.N., Lee E., Yu L.X., Jefferson E.H., and Hussain A.S. Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneity. AAPS Pharm. Sci. Technol. 3 (2002) 1-15
33. Gendrin C., Roggo Y., Spiegel C., and Collet C. Monitoring galenical process development by near infrared chemical imaging: one case study. Eur. J. Pharm. Biopharm. 68 (2008) 828-838
34. Lewis E.N., Carroll J.E., and Clarke F. A near infrared view of pharmaceutical formulation analysis. NIR News 12 (2001) 16-18
35. El-Hagrasy A.S., Morris H.R., D'Amico F., Lodder R.A., and Drennen III J.K. Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity. J. Pharm. Sci. 90 (2001) 1298-1307
36. Wolff J.-C., Warrack J.K., Kidder L., and Lewis E.N. NIR-based chemical imaging as an anticounterfeiting tool. Pharm. Manuf. 7 (2008) 27-31
37. International Conference of Harmonisation, ICH Q8: Pharmaceutical Development: Step 4 (2005) 1-11
38. Mutschler E., Geisslinger G., Kroemer H.K., and Schäfer-Korting M. β-Adrenozeptor-antagonisten. In: Mutschler E., Geisslinger G., Kroemer H.K., and Schäfer-Korting M. (Eds). Mutschler Arzneimittelwirkungen (2001), Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 342-348
39. Savitzky A., and Golay H.J.E. Smoothing and differentiation of data by simplified least squares procedures. Anal. Chem. 36 (1964) 1627-1639
40. Eigenvector Research Inc., Available from: http://software.eigenvector.com/toolbox/emsc_toolbox/index.html (2009) 1-1.
41. Martens H., Nielsen J.P., and Engelsen S.B. Light scattering and light absorbance separated by extended multiplicative signal correction. Application to near-infrared transmission analysis of powder mixtures. Anal. Chem. 75 (2003) 394-404
42. Ritschel W.A., and Bauer-Brandl A. Tablettenbestandteile. In: Ritschel W.A., and Bauer-Brandl A. (Eds). Die Tablette (2002), Editio Cantor Verlag, Aulendorf 60-207
43. Carli F., and Garbassi F. Characterization of drug loading in crospovidone by X-ray photoelectron spectroscopy. J. Pharm. Sci. 74 (1985) 963-967